New hope for inoperable kidney cancer: targeted radiation shows promise
NCT ID NCT05023265
First seen Apr 29, 2026 · Last updated Apr 29, 2026
Summary
This study is testing a highly focused type of radiation, called SBRT, for people with kidney cancer that cannot be removed with surgery. The goal is to see if this treatment can control the tumor for at least two years while keeping side effects low and maintaining quality of life. About 70 adults with newly diagnosed or recurrent kidney cancer will receive SBRT and be followed for outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunnybrook Health Sciences
RECRUITINGToronto, Ontario, Canada
Contact
Conditions
Explore the condition pages connected to this study.